Loading
Life sciences · Journal article
International Journal of Health and Pharmaceutical Research · October 1, 2026
No summary has been generated for this record yet. What follows is drawn from its source metadata only.
Journal article.
No findings were extractable from the material analysed.
Safety was not reported in the material analysed. Check the source before drawing any conclusion about harm.
The source did not state who this applies to in practice.
Graded across the dimensions that decide whether you should act, each from what the source actually supports. There is no single score, and where a dimension was not assessed it says so.
This record has not been graded across any dimension yet. Treat the label above as provisional and read the source.
What is missing. This record has no bottom line, key findings, reported figures, evidence dimensions. That is a gap in the analysis, not a judgement about the study.
Metabolic disorders, including diabetes, obesity, metabolic syndrome, and dyslipidemia, have become significant global health concerns due to their rising prevalence and association with increased morbidity and mortality. These disorders contribute to the growing burden of noncommunicable diseases (NCDs), which are now among the leading causes of death worldwide. The increasing incidence of metabolic disorders is driven by a complex interplay of genetic, behavioral, environmental, and socioeconomic factors. Rapid urbanization, sedentary lifestyles, unhealthy dietary patterns, and socioeconomic disparities have exacerbated the problem, particularly in low- and middle-income countries where healthcare access is limited. This study was conducted through an extensive literature review, synthesizing data from peerreviewed journals, global health reports, and epidemiological studies to assess the prevalence, associated risk factors, and management strategies for metabolic disorders across different populations. The findings indicate that while genetic susceptibility plays a role, lifestyle and environmental factors remain the most significant contributors to metabolic disorders. Industrialization and urban living have led to an increased intake of processed foods high in refined sugars and unhealthy fats, contributing to obesity and insulin resistance. Additionally, reduced physical activity and prolonged sedentary behavior have further heightened the risk of metabolic dysfunction. Effective management of metabolic disorders requires a comprehensive and multidisciplinary approach that includes early screening, lifestyle interventions, pharmacological treatments, and public health policies aimed at prevention. Innovations in medical technology, such as digital health tools, telemedicine, and personalized medicine, have enhanced the early diagnosis and treatment of these conditions. However, challenges persist in many regions, particularly those with healthcare inequities, limited resources, and a lack of awareness about preventive measures. Strengthening healthcare infrastructure, implementing public health initiatives, and promoting education on healthy living are crucial steps toward reducing the global burden of metabolic disorders. This review provides a detailed analysis of the epidemiology of metabolic disorders, explores their key determinants, and evaluates the effectiveness of current and emerging management strategies. Addressing these challenges through evidence-based policies, global collaborations, and improved healthcare access is essential for mitigating the long-term impact of metabolic disorders and enhancing overall population health.